CAS 548-30-1: 13-methyl[1,3]benzodioxolo[5,6-c][1,3]dioxolo[4,5-i]phenanthridin-14(13H)-one
Formula:C20H13NO5
InChI:InChI=1S/C20H13NO5/c1-21-18-12(3-2-10-6-15-16(7-13(10)18)25-8-24-15)11-4-5-14-19(26-9-23-14)17(11)20(21)22/h2-7H,8-9H2,1H3
InChI key:InChIKey=UFHGABBBZRPRJV-UHFFFAOYSA-N
SMILES:O=C1C=2C=3OCOC3C=CC2C4=CC=C5C=C6OCOC6=CC5=C4N1C
- Synonyms:
- (1,3)Benzodioxolo(5,6-c)-1,3-dioxolo(4,5-i)phenanthridin-14(13H)-one, 13-methyl-
- 8-Oxosanguinarine
- Hydroxysanguinarine
- Oxysanguinarine
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 7W-GY3878
Undefined size | To inquire |
Estimated delivery in United States, on Monday 3 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: BP-BP4389
10mg | 248.00 € | ||
20mg | 466.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Oxysanguinarine
CAS:548-30-1
Oxysanguinarine (Hydroxysanguinarine) possesses antiplatelet aggregation activity, it has potential inhibitory properties against the dengue virus.
Formula:
C20H13NO5
Purity:
99.57%
Color and Shape:
Solid
Molecular weight:
347.32
Ref: TM-TN2027
1mg | 60.00 € | ||
5mg | 144.00 € | ||
10mg | 227.00 € | ||
25mg | 375.00 € | ||
50mg | 560.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Hydroxysanguinarine
Controlled ProductCAS:548-30-1
Formula:
C20H13NO5
Color and Shape:
Neat
Molecular weight:
347.321
Ref: TR-H124670
50mg | 1,151.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Oxysanguinarine
CAS:548-30-1
Oxysanguinarine is a glycol ether compound that inhibits protein synthesis by binding to an active …
Formula:
C20H13NO5
Purity:
Min. 95%
Molecular weight:
347.3 g/mol
Ref: 3D-AAA54830
25mg | 1,034.00 € | ||
50mg | 1,354.00 € | ||
100mg | 2,166.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025